Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: Shionogi
Amyotrophic Lateral Sclerosis (ALS)
Japan
Sponsor: Boehringer Ingelheim
Pancreatic Neoplasms · Solid Tumors · Biliary Tract Cancer · Lung Neoplasms
United States, Australia, Austria, Belgium, France +11 more
- Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisActive Not Recruiting
Sponsor: Sanofi
Multiple Sclerosis
United States, Argentina, Austria, Belgium, Brazil +36 more
- Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)Active Not Recruiting
Sponsor: Daiichi Sankyo
Relapsed/Refractory Peripheral T-Cell Lymphoma · Adult T Cell Leukemia/Lymphoma
United States, Australia, Canada, France, Germany +7 more
Sponsor: Shionogi
Amyotrophic Lateral Sclerosis (ALS)
United States, Canada, France, Germany, Italy +1 more
Sponsor: AstraZeneca
Asthma
United States, Argentina, Brazil, Chile, China +16 more
- Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular DiseaseActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Atherosclerotic Cardiovascular Disease
United States, Argentina, Australia, Austria, Belgium +45 more
- ONO-4059 Study in Patients With Steroid-resistant PemphigusActive Not Recruiting
Sponsor: Ono Pharmaceutical Co., Ltd.
Pemphigus · Steroid-resistant Pemphigus
Japan
Sponsor: Eli Lilly and Company
Obesity · Overweight
United States, Belgium, Brazil, Israel, Italy +7 more
Sponsor: Chugai Pharmaceutical
Solid Tumors
United States, Japan
- A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsActive Not Recruiting
Sponsor: Eli Lilly and Company
Pancreatic Ductal Adenocarcinoma · Non-small Cell Lung Cancer · Colorectal Cancer · Advanced Solid Tumor
United States, Belgium, France, Germany, Italy +3 more
- The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)Active Not Recruiting
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Systemic Lupus Erythematosus
United States, Argentina, Australia, Brazil, Bulgaria +17 more
Sponsor: AstraZeneca
Carcinoma, Non-Small-Cell Lung
United States, Australia, Belgium, Brazil, Canada +15 more
Sponsor: Eli Lilly and Company
Obesity
Japan
- A Study in Participants With Obesity or Overweight With at Least One Weight-related ComorbidityCompleted
Sponsor: AstraZeneca
Obesity or Overweight
United States, Australia, Canada, Japan, United Kingdom
Sponsor: Novartis Pharmaceuticals
Chronic Spontaneous Urticaria
United States, Argentina, Canada, Chile, China +12 more
- A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System AtrophyRecruiting
Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Multiple System Atrophy
United States, France, Germany, Israel, Italy +3 more
- A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)Active Not Recruiting
Sponsor: Eli Lilly and Company
Atherosclerotic Cardiovascular Disease (ASCVD) · Elevated Lp(a)
United States, Argentina, Australia, Austria, Belgium +23 more
Sponsor: Washington University School of Medicine
Alzheimer's Disease
United States, Argentina, Australia, Brazil, Canada +8 more
Sponsor: Shionogi
ALS
United States, Canada, Germany, Italy, Japan +2 more
- AZD9291 in Combination With Ascending Doses of Novel TherapeuticsActive Not Recruiting
Sponsor: AstraZeneca
Advanced Non Small Cell Lung Cancer
United States, Canada, Japan, Poland, Russia +3 more
Sponsor: Eli Lilly and Company
Carcinoma, Non-Small-Cell Lung · Neoplasm Metastasis
United States, Australia, Austria, Belgium, Brazil +24 more
Sponsor: AstraZeneca
Acute Lymphoblastic Leukaemia · Acute Myeloid Leukaemia · Higher-risk Myelodysplastic Syndromes
United States, Australia, Canada, Denmark, Germany +4 more
Sponsor: Ono Pharmaceutical Co., Ltd.
Gastrointestinal Stromal Tumors
Japan
- Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)Enrolling By Invitation
Sponsor: Chugai Pharmaceutical
Antiphospholipid Syndrome (APS) · Bullous Pemphigoid (BP) · Behçet's Syndrome (BS) · Dermatomyositis (DM)
Australia, Austria, Bulgaria, Canada, Croatia +14 more